Central retinal vein occlusion (CRVO) is usually seen as a disease of the elderly, when it is frequently associated with arteriosclerotic or atherogenic disease elsewhere, glaucoma, or factors which affect blood coagulability and viscosity. It is less common in younger people. In two large studies' 2 of CRVO 11 of 116 patients (10%) and approximately 14 of 179 patients (8%) were aged 40 years or less.
Attention was first focused on these younger patients by Lyle and Wybar3 in 1961, who described seven patients, though on review probably only five of these had CRVO. These patients ranged in age from 24 to 49 years. The authors drew attention to the characteristic fundal appearances of unilateral disc swelling, namely, venous dilatation and peripheral retinal haemorrhages in the presence of good visual acuity. They emphasised a male preponderance and the fact that the patients were otherwise well and made a full visual recovery. Three patients were followed up for 3, 5, and 6 years respectively and suffered no further problems. In the absence of overt causes for the CRVO they postulated that a vasculitis of the central retinal vein was responsible, making an analogy with Eales' disease.
This report was followed by another description of five cases by Lonn and Hoyt,4 who coined the term 'papillophlebitis'. They thought the aetiology was inflammatory on the grounds that whitish sheathing of the retinal veins adjacent to the optic disc could be seen after the swelling had subsided. Soon afterwards further cases were published by Cogan,' Hart et al, 6 and Hayreh.7 The last two reports published fluorescein angiograms showing that the appearances were not dissimilar to those of non-ischaemic CRVO in older patients. Hart et al postulated that the better visual prognosis was due to the absence of associated arterial disease. All these authors, however, subscribed to From the hospital records we identified the date of presentation and age of the patients. Twenty-one patients were aged 40 or under at presentation, and these were selected for special study. Both records and colour photographs were available for only 17, and most of these had also had fluorescein angiography (Table I) . Particular attention was paid on review of the notes to any evidence of systemic disease on presentation and to the presence of possible aetiological factors such as hypertension, smoking, diabetes mellitus, the contraceptive pill, and a family history of vascular disease. As this was a retrospective study full data were not available for all patients, and these findings are summarised (Table II) together with the results of investigations at presentation (Table III) .
Central retinal vein occlusion was defined as venous dilatation with retinal haemorrhages scattered throughout the fundus to the periphery. The severity of the retinopathy was Central retinal vein occlusion in people aged 40years ofless: a review of17 patients the male/female ratios. The distribution of CRVO by age and sex is shown in Figure 1 .
rest Twenty-one patients (14-8%) were aged 40 years or younger. Of the 17 with full data available the average age was 315 years, with 10 8 men (average age 32-9 years) and 7 women (average 30 9 years). The age and sex distribution of these patients is shown in Figure 1 prior to the demarcation line. Of these 17 patients 12 were Caucasian, 2 Asian, 2 Negro, and 1 Arabic, which probably reflects the local population mixture at this time. Tables I to III summarise (24, 17 n mmHg), and none had overt glaucoma.
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As this was a selected group from a retrospective study, the information on systemic associations and abnormal investigations at presentation was not complete in all cases. However, because of their relative youth most were investigated carefully. Factors which are associated with atherogenesis or thrombosis (diabetes mellitus, smoking, obesity, contraceptive pill) were found in 10 patients (Table V) The follow-up postal questionnaire provided useful information (Table VI) and extended the average follow-up time from 35 3 months to 60-9 months (range 6 months to 9 years 3 months). Of the nine patients who responded to the question- Follow-up data on visual recovery were available for 11 of our 17 patients and showed a generally good prognosis (Fig 2, Table IV ), as others have found. Macular oedema was responsible for the poor visual recovery in three patients; one of these was associated with acute anterior uveitis and another with cilioretinal artery occlusion. The remaining seven patients (64%) improved to 6/9 or better. No patient developed rubeosis. The good visual prognosis in these patients contrasts with that expected in the elderly. Rubenstein and Jones'4 studied 143 patients aged 30 and over and found that 59% had a visual acuity of 6/18 or worse in the affected eye and 36% less than 6/60.
Only one patient in our series developed disease in the fellow eye during follow-up, and this patient (Q) was in many ways atypical. At 14 years of age he was the youngest patient in the series. He presented with an overt non-specific immunological illness with arthralgia and a CRVO in the left eye, erythrocyte sedimentation rate, anaemia, raised serum globulins, and inflammatory changes seen on a liver biopsy. Five months later he developed a CRVO in the fellow eye. He was treated with systemic steriods, and the retinopathy resolved, eventually leaving him with a visual acuity of 6/6 and 6/24 18 months later, the reduced acuity in the left eye being due to cilioretinal artery occlusion.
Patient Q was the only patient to have evidence of an inflammatory or immunological underlying disease process which might account for the CRVO. Patient F had ankylosing spondylitis, but this is not typically associated with systemic vasculitis and was probably coincidental to the retinopathy. Although 10 patients had conditions that predispose to premature vascular disease, they must be considered in the context of the general incidence in the population, and it is difficult to draw any conclusions that these conditions were responsible for the retinopathy. 1 with valvular heart disease, 1 with polymyositis, and 1 with polycycstic kidneys). The follow-up period for their patients ranged from three to 26 years (average 14 years), and a further eight patients acquired a systemic disease during that time. Two had hypertension, two suffered 'cardiac death', and four had systemic diseases judged to be unrelated to CRVO. They found (as we did) that the visual prognosis tended to be good and that the incidence of involvement of the other eye was minimal (in only two cases).
As to pathology, it seems reasonable to adopt Virchow's approach'9 regarding factors concerned in the causation of thrombosis. These are changes in the vessel wall, changes in the blood flow, and changes in the composition of the blood.
A Conditions such as hyperlipidaemia, paraproteinaemias, polycythaemia, increased platelet aggregation, and other hyperviscosity or hypercoagulability syndromes which result in changes in the composition of the blood (and its flow) have often been found in association with CRVO. These factors were not a prominent feature in our series but can undoubtedly be associated with CRVO,9 Be 15 24-26 and it is important to exclude them in all young patients. It does, however, appear that most young patients with CRVO have a uniocular loss with a low risk of involvement of the fellow eye, an extremely low chance of any systemic inflammatory illness being found, and a low risk of any underlying vascular or atherogenic disease. Prolonged follow-up in our series and others3'2 indicates that most patients continue to have excellent general health.
A hypothesis which might explain these findings would be the presence of a congenital anomaly in the central retinal vein at the lamina cribrosa causing turbulent flow and predisposing to thrombus formation.
We consider that young adults with CRVO require comprehensive physical examination and investigation. Our suggestions for these investigations are set out in Table VII. 
